ASCEND
BY NTHRYS
🎓

You are exploring a lot!

Register free to continue exploring ASCEND — access research frontiers, workshops, training modules and more.

Register Free →

NTHRYS › PhD Assistance › Pharmacogenetics

Pharmacogenetics

Field
▾
Category
▾

Pharmacogenetics

Select a category to explore research frontiers

CYP450 Enzyme Polymorphisms and Drug Metabolism
Explore frontiers →
HLA Allele Associations with Adverse Drug Reactions
Explore frontiers →
Warfarin Pharmacogenetics and Anticoagulation Management
Explore frontiers →
Thiopurine Methyltransferase Deficiency Screening
Explore frontiers →
Clopidogrel Responsiveness and CYP2C19 Loss-of-Function
Explore frontiers →
Statins Pharmacogenomics and Myopathy Risk Prediction
Explore frontiers →
TPMT and NUDT15 Variants in Leukemia Treatment
Explore frontiers →
Acetylator Phenotype and Isoniazid Hepatotoxicity
Explore frontiers →
DPYD Deficiency and Fluoropyrimidine Chemotoxicity
Explore frontiers →
Abacavir Hypersensitivity and HLA-B*5701 Screening
Explore frontiers →
Allopurinol Severe Cutaneous Adverse Reactions Genetics
Explore frontiers →
Carbamazepine and Phenytoin Hypersensitivity HLA Variants
Explore frontiers →
Codeine Metabolism and CYP2D6 Ultra-Rapid Metabolizers
Explore frontiers →
Metoprolol Response and CYP2D6 Polymorphisms
Explore frontiers →
Tacrolimus Bioavailability and CYP3A5 Genotyping
Explore frontiers →
Voriconazole Pharmacokinetics and CYP2C19 Variants
Explore frontiers →
SLCO1B1 Polymorphisms and Statin Drug Transporter
Explore frontiers →
Metformin Nephrotoxicity and OCT1 Transporter Variants
Explore frontiers →
Dihydrofolate Reductase Inhibitors and MTHFR Polymorphisms
Explore frontiers →
Methyltransferase Gene Variants and Drug Efficacy Prediction
Explore frontiers →
Epigenetic Modifications in Drug Response Heterogeneity
Explore frontiers →
MicroRNA Regulation of Pharmacogene Expression Networks
Explore frontiers →
Copy Number Variations in CYP2D6 Gene Locus
Explore frontiers →
Structural Variants and Drug Metabolism Gene Deletions
Explore frontiers →
Genome-Wide Association Studies for Drug Response Traits
Explore frontiers →
Whole Exome Sequencing and Rare Pharmacogenetic Variants
Explore frontiers →
Ancestry-Specific Pharmacogenetic Variant Frequencies
Explore frontiers →
Pharmacogenetics in Underrepresented Racial and Ethnic Groups
Explore frontiers →
Genotype-Phenotype Correlation in Metabolizer Classification
Explore frontiers →
Phenoconversion and Drug-Drug Interaction Enzymeinduction
Explore frontiers →
Personalized Warfarin Dosing Algorithms and Clinical Utility
Explore frontiers →
Cystic Fibrosis Transmembrane Conductance Regulator Modulators
Explore frontiers →
HER2 Mutation Status in Targeted Cancer Pharmacotherapy
Explore frontiers →
EGFR Mutation Testing for Personalized Lung Cancer Treatment
Explore frontiers →
KRAS Mutations and Cetuximab Resistance in Colorectal Cancer
Explore frontiers →
BRAF V600E Mutations and Melanoma Treatment Response
Explore frontiers →
PD-L1 Expression Biomarkers and Immunotherapy Response Prediction
Explore frontiers →
Pharmacogenetics of Psychotropic Drug Response and Side Effects
Explore frontiers →
CYP2C19 and Citalopram-Escitalopram Dosing Recommendations
Explore frontiers →
Lithium Pharmacogenetics and Therapeutic Drug Monitoring
Explore frontiers →
Solute Carrier Transporter Gene Polymorphisms and Drug Uptake
Explore frontiers →
ABC Transporter Gene Variants and Efflux-Mediated Resistance
Explore frontiers →
Vitamin K Epoxide Reductase Complex Warfarin Interaction
Explore frontiers →
Pharmacogenetic Testing Implementation in Clinical Practice
Explore frontiers →
Electronic Health Record Integration of Pharmacogenetic Data
Explore frontiers →
Machine Learning Prediction of Drug Response Phenotypes
Explore frontiers →
Polygenic Risk Scores for Medication Efficacy Prediction
Explore frontiers →
Organoid and In Vitro Models of Pharmacogenetic Prediction
Explore frontiers →
Pharmacogenomic Biobanks and Real-World Evidence Generation
Explore frontiers →
Pregnancy-Related Pharmacogenetics and Fetal Drug Exposure
Explore frontiers →
Pharmacogenetic Biomarkers in Triple-Negative Breast Cancer
Explore frontiers →
Long Non-Coding RNA Regulation of Drug Metabolism
Explore frontiers →
Mitochondrial DNA Variants and Drug Toxicity Susceptibility
Explore frontiers →
TPMT Allelic Variants in Indigenous Populations
Explore frontiers →
Drug Transporter Saturation and Pharmacokinetic Nonlinearity
Explore frontiers →
Tumor Microenvironment and Chemotherapy Pharmacogenetics
Explore frontiers →
Phase III Drug Conjugation Enzyme Polymorphisms
Explore frontiers →
Circadian Rhythm Genes and Temporal Drug Response
Explore frontiers →
Pharmacogenetics of Opioid Receptor Antagonist Response
Explore frontiers →
Ion Channel Gene Variants and Cardiac Arrhythmia Risk
Explore frontiers →
Pharmacogenomics of Proton Pump Inhibitor Metabolism
Explore frontiers →
Gut Microbiota Genetic Variation and Drug Bioactivation
Explore frontiers →
NUDT15 Deficiency and Thiopurine Toxicity Mechanisms
Explore frontiers →
Pharmacogenetic Counseling in Prenatal Care Settings
Explore frontiers →
Proteasome Inhibitor Response and Genetic Polymorphisms
Explore frontiers →
Epigenetic Histone Modification and Pharmacogene Silencing
Explore frontiers →
Statin-Induced Myopathy Genetic Risk Score Development
Explore frontiers →
Targeted Therapy in ALK-Rearranged Lung Adenocarcinoma
Explore frontiers →
Immunosuppressant Pharmacogenetics in Organ Transplantation
Explore frontiers →
Anti-TNF Therapy Response and Host Genetic Predictors
Explore frontiers →
Fluoroquinolone Pharmacogenomics and Tendinopathy Risk
Explore frontiers →
RNA Splicing Variants in Pharmacogene Expression
Explore frontiers →
Pharmacogenetics of Tyrosine Kinase Inhibitor Resistance
Explore frontiers →
Maternal Metabolizer Phenotype and Neonatal Drug Exposure
Explore frontiers →
Antiretroviral Pharmacogenomics in HIV Cure Research
Explore frontiers →
Topoisomerase Inhibitor Sensitivity and Repair Gene Variants
Explore frontiers →
Pharmacogenetic Data Interoperability and Standards Development
Explore frontiers →
Angiotensin Receptor Blocker Response and Genetic Polymorphisms
Explore frontiers →
Post-Transcriptional Modification and Pharmacogene Function
Explore frontiers →
Checkpoint Inhibitor Efficacy and Tumor Mutational Burden
Explore frontiers →
GABA Receptor Polymorphisms and Benzodiazepine Sensitivity
Explore frontiers →
Hepatic Fibrosis Progression and Drug Metabolism Decline
Explore frontiers →
Antimalarial Drug Resistance and Plasmodium Genomics
Explore frontiers →
Pharmacogenomics of Insulin Secretagogue Hypoglycemia Risk
Explore frontiers →
Three-Dimensional Protein Structure and Drug Binding Kinetics
Explore frontiers →
Glucocorticoid Receptor Polymorphisms and Steroid Responsiveness
Explore frontiers →
Liquid Biopsy Circulating Tumor DNA and Treatment Selection
Explore frontiers →
Serotonin Transporter Variants and Antidepressant Response
Explore frontiers →
Vancomycin Nephrotoxicity and Kidney-Specific Gene Variants
Explore frontiers →
Platinum Chemotherapy Ototoxicity and Auditory Pathway Genes
Explore frontiers →
Spatial Transcriptomics and Tissue-Specific Drug Metabolism
Explore frontiers →
Pharmacogenetics in Rare Genetic Disorder Drug Development
Explore frontiers →
Biofilm Formation Genetics and Antibiotic Pharmacokinetics
Explore frontiers →
Dosage Compensation and X-Linked Pharmacogene Expression
Explore frontiers →
Stochastic Gene Expression Noise and Drug Response Variability
Explore frontiers →
Pharmacogenomics of SGLT2 Inhibitor Diabetic Ketoacidosis
Explore frontiers →
Environmental Gene-Environment Interactions in Drug Response
Explore frontiers →
Anaphylaxis Susceptibility Genes and Drug Allergy Cross-Reactivity
Explore frontiers →
NAT2 Acetylator Phenotype and Drug Toxicity
Explore frontiers →
TPMT Activity Prediction in Immunosuppressive Therapy
Explore frontiers →
CYP2C9 Warfarin Interactions and Bleeding Risk
Explore frontiers →
UGT1A1 Polymorphisms and Irinotecan Toxicity
Explore frontiers →
TPMT and Mercaptopurine Acute Leukemia Treatment
Explore frontiers →
CYP2D6 Phenoconversion via Drug Interactions
Explore frontiers →
OPRM1 Genetic Variants and Opioid Response
Explore frontiers →
COMT Val158Met and Catecholamine Drug Response
Explore frontiers →
PNMT and Epinephrine Metabolism Polymorphisms
Explore frontiers →
MTHFR and Methotrexate Efficacy Prediction
Explore frontiers →
TPMT, NUDT15 and Thiopurine Combination Screening
Explore frontiers →
CYP3A4 Induction and Oral Contraceptive Failure
Explore frontiers →
NAT1 and NAT2 Substrate-Dependent Metabolism
Explore frontiers →
SULT1A1 and Minoxidil Hair Growth Response
Explore frontiers →
XDH and Allopurinol Metabolism Pharmacogenetics
Explore frontiers →
PON1 Paraoxonase and Organophosphate Drug Toxicity
Explore frontiers →
GSTM1 Glutathione S-Transferase Null Variants
Explore frontiers →
GSTP1 Polymorphisms and Chemotherapy Response
Explore frontiers →
GSTTZ1 and Doxorubicin-Induced Cardiomyopathy
Explore frontiers →
CYP2B6 Efavirenz Pharmacokinetics and CNS Toxicity
Explore frontiers →
CYP2C8 and Rosiglitazone Hepatotoxicity Risk
Explore frontiers →
CYP1A2 and Theophylline Toxicity Prediction
Explore frontiers →
CYP2E1 and Acetaminophen Hepatotoxicity Susceptibility
Explore frontiers →
SLCO1B1 and Pravastatin Myopathy Biomarkers
Explore frontiers →
SLCO1B1 and Rosuvastatin Plasma Concentration
Explore frontiers →
SLCO2B1 Substrate Specificity and Drug Uptake
Explore frontiers →
OCT2 and Metformin Renal Accumulation
Explore frontiers →
MATE1 and Cimetidine Drug Interactions
Explore frontiers →
MDR1 and P-glycoprotein Substrate Transport
Explore frontiers →
BCRP and Mitoxantrone Transporter Polymorphisms
Explore frontiers →
PMAT and Cation Drug Transport Variants
Explore frontiers →
Aromatase Inhibitor Metabolism and CYP19A1
Explore frontiers →
5-Lipoxygenase Inhibitor Response Pharmacogenetics
Explore frontiers →
Angiotensin Converting Enzyme Inhibitor Response
Explore frontiers →
Bradykinin B2 Receptor Variants and ACE Cough
Explore frontiers →
Beta-Adrenergic Receptor Polymorphisms and Response
Explore frontiers →
Angiotensinogen and Losartan Efficacy Prediction
Explore frontiers →
CYP11B2 and Aldosterone Antagonist Response
Explore frontiers →
HLA-B*1502 and Phenytoin Severe Reactions
Explore frontiers →
HLA-A*3101 and Carbamazepine Hypersensitivity
Explore frontiers →
HLA-DRB1 and Flucloxacillin Hepatotoxicity
Explore frontiers →
CYP2D6 Zygosity and Metabolizer Class Prediction
Explore frontiers →
CYP2D6 Gene Duplication and Ultrarapid Metabolism
Explore frontiers →
CYP2D6 Hybrid Genes and Functional Variants
Explore frontiers →
Digoxin Pharmacogenetics and MDR1 Transporter
Explore frontiers →
Dabigatran Metabolism and OATP1B1 Variants
Explore frontiers →
Apixaban Pharmacogenomics and CYP3A5
Explore frontiers →
Rivaroxaban Bioavailability and Transporter Variants
Explore frontiers →
POR Cytochrome P450 Reductase Polymorphisms
Explore frontiers →
Rare Pharmacogenetic Variants and Exome Sequencing
Explore frontiers →
NUDT15 Variants in Thiopurine Metabolism and Leukemia
Explore frontiers →
NAT2 Acetylator Status in Tuberculosis Drug Efficacy
Explore frontiers →
TPMT Allelic Diversity and Immunosuppressive Drug Safety
Explore frontiers →
CYP2C9 Variants and NSAID-Induced Gastric Ulceration
Explore frontiers →
GSTM1 Deletion and Chemotherapy Toxicity Susceptibility
Explore frontiers →
SLC22A2 Polymorphisms in Metformin Accumulation Risk
Explore frontiers →
IFNL3 Genotype Prediction in Hepatitis C Antiviral Response
Explore frontiers →
IL28B Polymorphisms and Pegylated Interferon Treatment Outcomes
Explore frontiers →
CYP3A7 Expression in Pediatric Drug Metabolism Ontogeny
Explore frontiers →
OPRM1 Mu-Opioid Receptor Variants and Analgesic Efficacy
Explore frontiers →
COMT Val158Met Polymorphism in Psychotropic Drug Response
Explore frontiers →
Brain-Derived Neurotrophic Factor Variants in Antidepressant Response
Explore frontiers →
MTHFR Polymorphisms in Methotrexate Toxicity Prediction
Explore frontiers →
ADORA2A Caffeine Sensitivity and CYP1A2 Interaction
Explore frontiers →
CYP2D6 Gene Duplication and Codeine Toxicity in Children
Explore frontiers →
VKORC1 and CYP2C9 Integrated Warfarin Dosing Algorithms
Explore frontiers →
HLA-B*1502 Screening in Carbamazepine-Induced SJS-TEN
Explore frontiers →
CYP2B6 Variants in HIV Protease Inhibitor Metabolism
Explore frontiers →
G6PD Deficiency Variants and Antimalarial Drug Safety
Explore frontiers →
Dihydropyrimidine Dehydrogenase Variants and 5-FU Toxicity
Explore frontiers →
SLCO1B1 Variants and Rosuvastatin-Induced Myopathy Risk
Explore frontiers →
CYP1A2 Polymorphisms in Theophylline Therapeutic Drug Monitoring
Explore frontiers →
UGT1A1 Variants in Irinotecan Glucuronidation and Toxicity
Explore frontiers →
TPMT Phenotyping Methods and Genotype-Phenotype Discordance
Explore frontiers →
Mitochondrial DNA Variants in Drug-Induced Lactic Acidosis
Explore frontiers →
CYP2C19 Loss-of-Function Variants in Proton Pump Inhibitors
Explore frontiers →
APOE Genotype and Statin-Induced Cognitive Changes
Explore frontiers →
GSTM1 and GSTT1 Null Variants in Acetaminophen Hepatotoxicity
Explore frontiers →
LDLR Mutations in Statin Response and Familial Hypercholesterolemia
Explore frontiers →
Ethnicity-Specific CYP2D6 Allele Frequencies and Drug Metabolism
Explore frontiers →
PON1 Polymorphisms in Statin and Arylesterase Activity
Explore frontiers →
CYP4F2 Variants in Vitamin K-Dependent Coagulation Control
Explore frontiers →
ADORA2A Genotype and Caffeine-Induced Anxiety Disorders
Explore frontiers →
SLC6A4 Serotonin Transporter Polymorphisms and SSRI Response
Explore frontiers →
HLA-B*5701 Screening Protocol Optimization in HIV Treatment
Explore frontiers →
N-Acetyltransferase 1 Variants in Doxorubicin Cardiotoxicity
Explore frontiers →
CYP19A1 Variants in Aromatase Inhibitor Response Prediction
Explore frontiers →
TGFB1 Variants in Chemotherapy-Induced Pulmonary Fibrosis
Explore frontiers →
UGT2B7 Variants in Morphine Glucuronidation and Efficacy
Explore frontiers →
CYP11B2 Polymorphisms in Aldosterone Synthase Activity
Explore frontiers →
CRHR1 Stress Receptor Variants in Antidepressant Treatment Response
Explore frontiers →
Human Platelet Antigen Diversity in Drug Immunogenicity
Explore frontiers →
GRIN2B N-Methyl-D-Aspartate Receptor Variants in Anesthesia
Explore frontiers →
CYP2A6 Variants in Nicotine Metabolism and Smoking Cessation
Explore frontiers →
GSTM3 Variants in Chemotherapy and Environmental Toxin Exposure
Explore frontiers →
Rare Genetic Variants in Orphan Pharmacogenetics Populations
Explore frontiers →
Polygenic Risk Scores for Medication Adverse Event Prediction
Explore frontiers →
CRISPR-Cas9 Gene Editing Models for Drug Metabolism Testing
Explore frontiers →
Intestinal Microbiota Dysbiosis and Drug Metabolism Alterations
Explore frontiers →
Pharmacogenomic Biobank Data Mining for Real-World Outcomes
Explore frontiers →
Pharmacogenetic Interactions in Polypharmacy Management
Explore frontiers →
Non-coding RNA Variants and Drug Response Modulation
Explore frontiers →